XBRU
SOLV
Market cap2.06bUSD
Sep 17, Last price
84.00EUR
1D
0.00%
1Q
7.69%
Jan 2017
-26.51%
Name
Solvac SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Solvac S.A. is a Belgian enterprise specializing in advanced materials and niche chemical solutions. Its diverse product portfolio encompasses specialty polymers, composite materials, soda ash, peroxides, and silica. Established in 1983, the company maintains its primary corporate offices in Brussels, Belgium.
Key people
Jean Solvay
Independent Chairman of the Board · since 2021
Management, General Secretary · since 2021
John Kraft De La Saulx
Director · since 2007
Patrick Solvay
Director · since 1997
Laure De Beaulieu
Independent Director · since 2015
Marion De Decker
Independent Director · since 2018
Baron De Dorlodot
Independent Director · since 2018
Marc-Eric De La Boessiere-Thiennes
Independent Director · since 2010
Savina De Limon Triest
Independent Director · since 2017
Valentine Delwart
Independent Director
Guy De Selliers De Moranville
Independent Director · since 2015
Vincent Dorlodot
Independent Director · since 2018
Pimodan Melody
Independent Director · since 2019
Jean-Patrick Mondron
Independent Director · since 2010
Olivia Rolin
Independent Director · since 2020
Melchior Vogue
Independent Director · since 2022
Headquarters & legal address
RUE DES CHAMPS ELYSÉES 43
BRUSSELS, BRU 1050
BE
BRUSSELS, BRU 1050
BE
Previous name
SOLVAC SA
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||